Cargando…

Inflammation in heart failure /

Inflammation in Heart Failure, edited by W. Matthijs Blankesteijn and Raffaele Altara, is the first book in a decade to provide an in-depth assessment on the causes, symptoms, progression and treatments of cardiac inflammation and related conditions. This reference uses two decades of research to in...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Blankesteijn, Matthijs (Editor ), Altara, Raffaele (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Academic Press, [2015]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_ocn898069526
003 OCoLC
005 20231120111924.0
006 m o d
007 cr cnu|||unuuu
008 141212t20152015ne a ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d EBLCP  |d N$T  |d UIU  |d YDXCP  |d OCLCF  |d VLB  |d TEFOD  |d VLB  |d RTH  |d U3W  |d D6H  |d WYU  |d OCLCA  |d AU@  |d CUY  |d LOA  |d OCLCQ  |d ZCU  |d MERUC  |d OCLCO  |d MERER  |d ICG  |d K6U  |d COCUF  |d OCLCQ  |d VT2  |d DKC  |d FEM  |d IDEBK  |d OCLCQ  |d LQU  |d OCLCQ  |d OCLCA  |d S2H  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO 
019 |a 899566324  |a 904095877  |a 968099591  |a 969037294  |a 1048426496  |a 1066677778  |a 1088964073  |a 1105173911  |a 1105565061  |a 1228620885 
020 |a 9780128004852  |q (electronic bk.) 
020 |a 0128004851  |q (electronic bk.) 
020 |a 1336008873 
020 |a 9781336008878 
020 |z 9780128000397 
020 |z 0128000392 
035 |a (OCoLC)898069526  |z (OCoLC)899566324  |z (OCoLC)904095877  |z (OCoLC)968099591  |z (OCoLC)969037294  |z (OCoLC)1048426496  |z (OCoLC)1066677778  |z (OCoLC)1088964073  |z (OCoLC)1105173911  |z (OCoLC)1105565061  |z (OCoLC)1228620885 
050 4 |a RC682  |b .I54 2015eb 
060 4 |a 2015 B-431 
060 4 |a WG 370 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.129 
245 0 0 |a Inflammation in heart failure /  |c edited by Matthijs Blankesteijn and Raffaele Altara. 
264 1 |a Amsterdam :  |b Academic Press,  |c [2015] 
264 4 |c �2015 
300 |a 1 online resource :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
504 |a Includes bibliographical references and index. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed December 30, 2014). 
505 0 |a Front Cover; Inflammation in Heart Failure; Copyright; Contents; Contributors; Preface; Section 1: Pathophysiology of the Inflammatory Response in Heart Failure; Chapter 1: Inflammation in Heart Failure with Preserved Ejection Fraction; 1.1. Introduction; 1.2. Consequences of Limited Understanding of Pathophysiology in HFpEF; 1.3. Underlying Causes of HFpEF; 1.4. Adaptive Mechanisms in HFpEF; 1.5. Inflammation in HFpEF; 1.5.1. Inflammation in HFpEF Animal Studies; 1.5.1.1. Interactions with Other Systems; 1.5.2. Inflammation in HFpEF Human Studies. 
505 8 |a 1.6. Oxidative Stress, Endothelial Dysfunction and Microvascular Disease1.6.1. Potential Implications for Treatment of HFpEF; 1.7. Conclusions; References; Chapter 2: Role of the Innate Immune System in Ischemic Heart Failure; 2.1. Introduction; 2.2. Initiation of the Immune Response; 2.2.1. Receptors; 2.2.2. Complement; 2.2.3. Oxidative Stress; 2.2.3.1. ROS Generation Post- MI ; 2.2.3.2. Role of Oxidative Stress for Cardiac Necrosis and Inflammation; 2.2.4. Mechanical Stimuli; 2.3. Effectors of Innate Immunity; 2.3.1. Cytokines; 2.3.1.1. Cytokine Effects on Cardiomyocyte Survival. 
505 8 |a 2.3.1.2. Cytokines Influence Granulation Tissue Formation and Vascular Remodeling Post-injury2.3.1.3. Cytokines Modulate Scar Tissue Formation After Injury; 2.3.1.4. Cytokines and ROS ; 2.3.1.5. Cytokines in Inflammation Resolution; 2.3.2. Cellular Effectors; 2.3.2.1. Leukocyte Recruitment; 2.3.2.2. Neutrophils; 2.3.2.2.1. Neutrophil-Mediated Cardiac Injury; 2.3.2.2.1.1. Reactive Oxygen Species; 2.3.2.2.1.2. Granule Toxicity; 2.3.2.3. Mononuclear Cells; 2.3.2.3.1. Monocytes; 2.3.2.3.2. Macrophages; 2.4. Reverse Remodeling. 
505 8 |a 2.5. Clinical Implications: Is There a Causal Link Between Dysequilibrated Inflammation and Remodeling?References; Chapter 3: The Role of Inflammation in Myocardial Infarction; 3.1. Introduction; 3.2. Role of the Inflammatory Response Before MI; 3.2.1. Development of the Atherosclerotic Plaque; 3.2.2. Immune Cells Involved; 3.2.3. Maturation and Rupture of the Atherosclerotic Plaque; 3.3. The Role of the Inflammatory Response in MI; 3.3.1. MI and Wound Healing; 3.3.2. Humoral Immune Response Post-MI; 3.3.2.1. Cytokines; 3.3.2.2. Chemokines; 3.3.3. Cellular Immune Response Post-MI. 
505 8 |a 3.3.3.1. Leukocytes3.3.3.2. Monocytes; 3.3.3.3. Macrophages; 3.3.3.4. Nonimmune Cells; 3.3.4. Other Factors Modulating the Immune Response Post-MI; 3.4. Inflammation as a Pharmacological and Biocellular Target; 3.4.1. Therapy Aimed at Inflammation Before MI; 3.4.1.1. Current Pharmacotherapy Targeting Inflammation Before MI; 3.4.1.1.1. Statins; 3.4.1.1.2. Hypoglycemic Agents; 3.4.1.1.3. Renin Angiotensin System Targeting; 3.4.1.1.4. P2Y 12 Receptor Inhibitors; 3.4.1.2. Novel Strategies Targeting Inflammation Before MI; 3.4.2. Therapy Aimed at Inflammation After MI. 
520 |a Inflammation in Heart Failure, edited by W. Matthijs Blankesteijn and Raffaele Altara, is the first book in a decade to provide an in-depth assessment on the causes, symptoms, progression and treatments of cardiac inflammation and related conditions. This reference uses two decades of research to introduce new methods for identifying inflammatory benchmarks from early onset to chronic heart failure and specifically emphasizes the importance of classifying at-risk subgroups within large populations while determining the patterns of cytokines in such classifications. Further, the book details c. 
546 |a English. 
650 0 |a Heart failure. 
650 0 |a Inflammation. 
650 0 |a Biochemical markers. 
650 1 2 |a Heart Failure  |x physiopathology  |0 (DNLM)D006333Q000503 
650 2 |a Heart Failure  |0 (DNLM)D006333 
650 2 |a Inflammation  |0 (DNLM)D007249 
650 2 2 |a Biomarkers  |0 (DNLM)D015415 
650 2 2 |a Hydroxymethylglutaryl-CoA Reductase Inhibitors  |x therapeutic use  |0 (DNLM)D019161Q000627 
650 2 2 |a Inflammation  |x physiopathology  |0 (DNLM)D007249Q000503 
650 2 2 |a Mineralocorticoid Receptor Antagonists  |x therapeutic use  |0 (DNLM)D000451Q000627 
650 2 2 |a Myocardial Infarction  |x physiopathology  |0 (DNLM)D009203Q000503 
650 2 2 |a Peroxisome Proliferator-Activated Receptors  |x therapeutic use  |0 (DNLM)D047492Q000627 
650 6 |a Insuffisance cardiaque.  |0 (CaQQLa)201-0036502 
650 6 |a Inflammation (Pathologie)  |0 (CaQQLa)201-0026988 
650 6 |a Marqueurs biologiques.  |0 (CaQQLa)201-0177920 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Biochemical markers  |2 fast  |0 (OCoLC)fst00831950 
650 7 |a Heart failure  |2 fast  |0 (OCoLC)fst00953724 
650 7 |a Inflammation  |2 fast  |0 (OCoLC)fst00972432 
700 1 |a Blankesteijn, Matthijs,  |e editor. 
700 1 |a Altara, Raffaele,  |e editor. 
776 0 8 |i Print version:  |t Inflammation in heart failure.  |d Amsterdam : Elsevier/Academic Press, [2015]  |z 9780128000397  |w (OCoLC)905685270 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128000397  |z Texto completo